News

The NYC–DSA’s viciousness will spell the end of whatever scant power it has gained in New York City over the past half-decade. There is no coming back from this. The mystery is why mainstream New York ...
SINGAPORE: For some Direct School Admission (DSA) entry points such as team sports and arts-related fields, the selection process contains a layer of subjectivity that makes it difficult to decide ...
File photo. The DSA scheme allows students to use their talents to secure admission into secondary schools or junior colleges before they even sit for the Primary School Leaving Examination (PSLE ...
The group has been riven by conflict over its stated commitment to the Boycott, Divestment, and Sanctions movement—and things are coming to a head at its national convention. Riot police stand ...
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, informs its investors that it does not hold cash deposits or securities ...
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the 5th Annual Evercore ISI ...
He is one of six DSA members in the state Senate and Assembly, who are collectively known as the Socialists in Office. The first socialist in office in the modern era was Julia Salazar, who was first ...
The leftist lawmakers, all of them national celebrities, have promoted DSA and partnered with the organization on crucial legislation. In turn, young socialists have flocked to the insurgent ...
Shares of DBV Technologies tumbled 8.5% in premarket trading on Wednesday, the day after the company said it had received a complete response letter from the Food and Drug Administration for its ...
Two of the leaders responsible for regulatory and product development at DBV Technologies are set to leave the company this month. The departures deprive DBV of senior members of its regulatory ...
DBV Technologies has withdrawn the filing for FDA approval of its peanut allergy therapy. The French biotech pulled the BLA after talks with the agency revealed gaps in the manufacturing and ...
libcom: First of all thanks for talking to us. The main DSA twitter account once said of libcom.org "they get mad at us all the time on here lol", which let's face it is not wrong. Generally as ...